Brought to you by MuOUT®
Challenge 1: Poor Adherence to Treatment
| Low treatment adherence accounts for poor outcomes in two-thirds of children with functional constipation.2,3 |
| PEG therapy offers a promising solution, with 90% compliance in long-term treatment.1 |  |
Why PEG Works:1 Excellent palatability leading to improved adherence. |
Challenge 2: Misconceptions About Long-Term Laxative Use
| Parents of children with constipation often hesitate to use laxatives for extended periods, fearing dependency on the medication.4 |
| Does NOT interfere with gut nerves or muscles |
However, PEG:5  |
Does NOT lead to dependency or damage |
 |
Effective treatment combined with gradual tapering for at least 1 month after symptom resolution helps prevent dependency concerns.6 |
Challenge 3: Persistent Constipation Despite Treatment
| ~16% of children experience persistent symptoms even with laxative use.7 Complete management should incorporate lifestyle changes along with laxatives to support long-term relief.8 |
| Here are some simple tips you can share with parents to get rid of constipation in children:9 |
 |
Encourage dietary changes that support regular bowel movements: • Include fruits, vegetables, and whole grains. • Boost fluid intake, especially water. • Limit fast foods, junk foods, and caffeine. • Establish regular mealtimes. |
 |
Encourage physical activity to support digestion and regularity: • Preschoolers should stay active all day. • Children aged 6–17 years need 60 minutes of daily moderate-to-vigorous exercise. |
 |
Emphasize on creating a positive routine around bathroom time: • Encourage 10 minutes on the toilet after meals. • Use rewards and encouragement. |
| Through PEG’s gentle and effective approach, combined with lifestyle modifications, pediatric constipation can be managed successfully—, helping children achieve lasting relief.1,8 |  |
Abbreviations ▼
PEG: Polyethylene glycol.
References ▼
1. Pashankar DS, Loening-Baucke V, Bishop WP, et al. Safety of polyethylene glycol 3350 for the treatment of chronic constipation in children. Arch Pediatr Adolesc Med. 2003;157(7):661–664. 2. Shen H, Zhang L, Zhang Y, et al. Facilitators and barriers of adherence to rectal interventions by parents of young children with functional constipation: A qualitative study. Front Pediatr. 2024;12:1417389. 3. Steiner SA, Torres MR, Penna FJ, et al. Chronic functional constipation in children: Adherence and factors associated with drug treatment. J Pediatr Gastroenterol Nutr. 2014;58(5):598–602. 4. Santucci NR, Chogle A, Leiby A, et al. Non-pharmacologic approach to pediatric constipation. Complement Ther Med. 2021;59:102711. 5. NASPGHAN Neurogastroenterology and Motility Committee. Polyethylene Glycol 3350 (PEG 3350) Frequently Asked Questions. Available at: https://www.gikids.org/files/PEG%203350%20FAQ%20-%20formatted.pdf. Accessed on: 15 November 2024. 6. Rajindrajith S, Devanarayana NM, Thapar N, et al. Myths and misconceptions about childhood constipation. Eur J Pediatr. 2023;182(4):1447–1458. 7. Ala S, Haghighat M, Dehghani SM, et al. Response and recurrence rate after treatment with polyethylene glycol versus polyethylene glycol plus lactulose in children with chronic functional constipation: A randomized controlled trial. J Compr Ped. 2015;6(2):e26119. 8. Chowdhury K, Sinha S, Kumar S, et al. Constipation: A pristine universal pediatric health delinquent. Cureus. 2024;16(1):e52551. 9. Johns Hopkins Medicine. Constipation in children. Available at: https://www.hopkinsmedicine.org/health/conditions-and-diseases/ constipation-in-children. Accessed on: 15 November 2024.
LMRC Code: GGI-CO-A1-AQS-300024228-ELC-L24-0094
Disclaimer: For the use of a Registered Medical Practitioner, Hospital or Laboratory only.
The images are for illustrative representation only and do not depict actual medical products, procedures, or outcomes. Refer to official medical guidance and product information for accurate details.
All content including: text, images, audio, or other formats were created for medical educational purposes only. Offerings for continuing education are clearly identified and the appropriate target audience is identified. This communication is restricted for the use of HCPs and must not be shared in public domain. The opinions expressed in this video are solely the views of the speaker. The presentation may contain off label usage of drug(s) aimed at educational purpose only. Dr. Reddy’s Laboratories Ltd including but not limited its Affiliates strictly does not recommend any off label usage of its marketing products. Prior to treatment kindly refer to the latest prescribing information approved by the local authorities. No part of this content may be used, reproduced, transmitted or stored in any form without the written permission of Dr. Reddy’s.